CompletedNCT03689543
Estrogen Receptor Beta and Mood During Perimenopause
About this title
Read the official source — NCT03689543Medication studyAges 45–65United StatesDepression
Understand this study
Who was this study for?
Listed age limits: 45 years to 65 years.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: May 23, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 74
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 45 Years to 65 Years
- Official registry ID
- NCT03689543
- Official title
Show the full official title
The Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-withdrawal-induced Mood Symptoms in Women With Past Perimenopausal Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Did this study involve medication?
Yes. The study involved medication, including Estradiol, ER Beta Agonist and Provera.
Who was this study for?
Listed age limits: 45 years to 65 years.
